These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37806433)

  • 21. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
    Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
    Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group.
    Berlato D; Bulman-Fleming J; Clifford CA; Garrett L; Intile J; Jones P; Kamstock DA; Liptak JM; Pavuk A; Powell R; Rasotto R
    Vet Pathol; 2021 Sep; 58(5):858-863. PubMed ID: 33888024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
    Sirohi D; Schmidt RL; Aisner DL; Behdad A; Betz BL; Brown N; Coleman JF; Corless CL; Deftereos G; Ewalt MD; Fernandes H; Hsiao SJ; Mansukhani MM; Murray SS; Niu N; Ritterhouse LL; Suarez CJ; Tafe LJ; Thorson JA; Segal JP; Furtado LV
    J Mol Diagn; 2020 Feb; 22(2):284-293. PubMed ID: 31837433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer.
    Bartley AN; Mills AM; Konnick E; Overman M; Ventura CB; Souter L; Colasacco C; Stadler ZK; Kerr S; Howitt BE; Hampel H; Adams SF; Johnson W; Magi-Galluzzi C; Sepulveda AR; Broaddus RR
    Arch Pathol Lab Med; 2022 Oct; 146(10):1194-1210. PubMed ID: 35920830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor DNA Assays in Clinical Cancer Research.
    Ossandon MR; Agrawal L; Bernhard EJ; Conley BA; Dey SM; Divi RL; Guan P; Lively TG; McKee TC; Sorg BS; Tricoli JV
    J Natl Cancer Inst; 2018 Sep; 110(9):929-934. PubMed ID: 29931312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.
    Sever C; Abbott CL; de Baca ME; Khoury JD; Perkins SL; Reichard KK; Taylor A; Terebelo HR; Colasacco C; Rumble RB; Thomas NE
    Arch Pathol Lab Med; 2016 Sep; 140(9):932-49. PubMed ID: 26905483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists.
    Hanna MG; Olson NH; Zarella M; Dash RC; Herrmann MD; Furtado LV; Stram MN; Raciti PM; Hassell L; Mays A; Pantanowitz L; Sirintrapun JS; Krishnamurthy S; Parwani A; Lujan G; Evans A; Glassy EF; Bui MM; Singh R; Souers RJ; de Baca ME; Seheult JN
    Arch Pathol Lab Med; 2024 Oct; 148(10):e335-e361. PubMed ID: 38041522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
    Soscia R; Della Starza I; De Novi LA; Ilari C; Ansuinelli M; Cavalli M; Bellomarino V; Cafforio L; Di Trani M; Cazzaniga G; Fazio G; Santoro A; Salemi D; Spinelli O; Tosi M; Terragna C; Robustelli V; Bellissimo T; Colafigli G; Breccia M; Chiaretti S; Di Rocco A; Martelli M; Guarini A; Del Giudice I; Foà R
    Hematol Oncol; 2023 Feb; 41(1):50-60. PubMed ID: 36251440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of cell-free DNA for molecular pathology.
    Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
    J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction.
    Gabriel E; Bagaria SP
    Front Oncol; 2018; 8():297. PubMed ID: 30128304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.
    Faragalla H; Plotkin A; Barnes P; Lu FI; Kos Z; Mulligan AM; Bane A; Nofech Mozes S
    Curr Oncol; 2023 Mar; 30(3):3079-3090. PubMed ID: 36975446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
    Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
    Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.
    Compton CC; Fielding LP; Burgart LJ; Conley B; Cooper HS; Hamilton SR; Hammond ME; Henson DE; Hutter RV; Nagle RB; Nielsen ML; Sargent DJ; Taylor CR; Welton M; Willett C
    Arch Pathol Lab Med; 2000 Jul; 124(7):979-94. PubMed ID: 10888773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG Oncology.
    Sho S; Yothers G; Colangelo LH; Ganz PA; O'Connell MJ; Beart RW; Hemmelgarn M; Chen FC; Ko CY; Russell MM
    Dis Colon Rectum; 2020 Aug; 63(8):1063-1070. PubMed ID: 32692071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.
    Compton CC; Robb JA; Anderson MW; Berry AB; Birdsong GG; Bloom KJ; Branton PA; Crothers JW; Cushman-Vokoun AM; Hicks DG; Khoury JD; Laser J; Marshall CB; Misialek MJ; Natale KE; Nowak JA; Olson D; Pfeifer JD; Schade A; Vance GH; Walk EE; Yohe SL
    Arch Pathol Lab Med; 2019 Nov; 143(11):1346-1363. PubMed ID: 31329478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma
    Dabbs D; Mittal K; Heineman S; Whitworth P; Shah C; Savala J; Shivers SC; Bremer T
    Front Oncol; 2023; 13():1069059. PubMed ID: 37274253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4.
    Crothers BA; Jones BA; Cahill LA; Moriarty AT; Mody DR; Tench WD; Souers RJ
    Arch Pathol Lab Med; 2013 Feb; 137(2):199-213. PubMed ID: 23368862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and opportunities in the adoption of College of American Pathologists checklists in electronic format: perspectives and experience of Reporting Pathology Protocols Project (RPP2) participant laboratories.
    Hassell LA; Parwani AV; Weiss L; Jones MA; Ye J
    Arch Pathol Lab Med; 2010 Aug; 134(8):1152-9. PubMed ID: 20670135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.